CCM
TPTX

Crabel Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Crabel Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,658
Closed -$7.58M – 85
2022
Q2 		$7.58M Buy
+100,658
New +$4.47M 3.98% 4

Crabel Capital Management's TPTX Position: Q3 2022 in Review

Crabel Capital Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 100,658 shares — an estimated $7.58M sold.

Crabel Capital Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $7.58M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Crabel Capital Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Crabel Capital Management sold 100,658 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $7.58M.
  • Crabel Capital Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Crabel Capital Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $7.58M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Crabel Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.